IndiaTickerBiogen Pharmachem Industries Ltd - 531752 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.BSE · exchange filing · pdf
Source filing Company dossier
Biogen Pharmachem
BSE:BIOGEN · ISIN INE703D01023
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Biogen Pharmachem
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Biogen Pharmachem Industries Ltd - 531752 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Announcement under Regulation 30 (LODR)-AllotmentBSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March, 2026 And Outcome Of The Board Meeting Held On Thursday 14Th May 2026.BSE · financial results · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")BSE · financial results · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotBSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationBSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Regulation 42 As Per SEBI LODR Intimation Of Record Date For Issuance Of Bonus Shares In The Proportion Of 1:6 I.E. 1 (One) New Equity Shares Of Rs.1/- Each For Every 6 (Six) Existing Equity Shares Of Rs.1/- Each Fully Paid Up And Held By The Members/ Beneficial OwnerBSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Shareholder Meeting / Postal Ballot-Notice of Postal BallotBSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Clarification For Point No 4 Of The Outcome In Reference To The Outcome Uploaded Of The Board Meeting Held On 23Rd March 2026.BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Regulations 30 Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Board Recommends The Issuance Of Fully Paid-Up Bonus Shares In The Ratio Of 1:6.BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 23Rd March 2026BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Intimation for Declaration Of Issue Of Bonus Shares.BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · financial results · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 11Th February 2026.BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sBSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsBSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Updation Of Website Of The Company.
BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Intimation for Reschedule Board Meeting As Per Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 7Th November 2025.BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · financial results · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
BSE · exchange filing · pdf
Source filing Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board MeetingBSE · exchange filing · pdf
Source filing